Aerius International Inc

PINK:AERS USA Shell Companies
Market Cap
$404.64K
Market Cap Rank
#50662 Global
#15493 in USA
Share Price
$0.00
Change (1 day)
+0.00%
52-Week Range
$0.00 - $0.00
All Time High
$0.03
About

Aerius International, Inc. provides consulting, design, construction, and financing services for marijuana operators in the United States. The company was founded in 2000 and is based in Las Vegas, Nevada.

Aerius International Inc (AERS) - Net Assets

Latest net assets as of June 2025: $-66.88K USD

Based on the latest financial reports, Aerius International Inc (AERS) has net assets worth $-66.88K USD as of June 2025.

Net assets (also known as shareholders' equity or book value) represent the difference between a company's total assets ($74.00) and total liabilities ($66.96K). This figure indicates the residual interest in the assets after deducting liabilities, essentially showing what would remain for shareholders if all assets were liquidated and all debts paid off.

Key Net Assets Metrics

Metric Value
Current Net Assets $-66.88K
% of Total Assets -90382.43%
Annual Growth Rate N/A
5-Year Change N/A
10-Year Change N/A
Growth Volatility N/A

Aerius International Inc - Net Assets Trend (2008–2024)

This chart illustrates how Aerius International Inc's net assets have evolved over time, based on quarterly financial data. Explore and compare other companies by net assets.

Annual Net Assets for Aerius International Inc (2008–2024)

The table below shows the annual net assets of Aerius International Inc from 2008 to 2024.

Year Net Assets Change
2024-12-31 $-51.84K -73.98%
2023-12-31 $-29.80K -30.12%
2022-12-31 $-22.90K -215.98%
2021-12-31 $-7.25K +98.70%
2017-12-31 $-557.96K 0.00%
2016-12-31 $-557.96K -5.25%
2015-12-31 $-530.15K -51.91%
2014-12-31 $-348.99K +51.13%
2012-12-31 $-714.19K -5.72%
2011-12-31 $-675.52K +25.74%
2010-12-31 $-909.64K -50.92%
2009-12-31 $-602.75K -67.94%
2008-12-31 $-358.91K --

Equity Component Analysis

This analysis shows how different components contribute to Aerius International Inc's total equity over time. Equity components include common stock, retained earnings, additional paid-in capital, and other elements.

Equity Composition Insights

  • Retained earnings have decreased by 93241100.0% over the analyzed period, potentially due to dividend distributions or operating losses.

Current Equity Component Breakdown (December 2024)

Component Amount Percentage
Common Stock $224.80K %
Other Comprehensive Income $25.00K %
Other Components $1.10 Million %
Total Equity $-51.84K 100.00%

Aerius International Inc Competitors by Market Cap

The table below lists competitors of Aerius International Inc ranked by their market capitalization.

Equity Growth Attribution

This analysis shows how different factors contributed to changes in Aerius International Inc's equity between the two most recent reporting periods.

Equity Growth Insights

  • From 2023 to 2024, total equity changed from -29,799 to -51,844, a change of -22,045.
  • Net loss of 22,545 reduced equity.
  • Other factors increased equity by 500.

Equity Change Factors (2023 to 2024)

Factor Impact Contribution
Net Income $-22.55K -43.49%
Other Changes $500.00 +0.96%
Total Change $- %

Book Value vs Market Value Analysis

This analysis compares Aerius International Inc's book value (net assets) with its market value over time. The relationship between these values can provide insights into investor sentiment and company valuation.

Valuation Insights

Historical Price-to-Book Ratios

Date Book Value per Share Market Price P/B Ratio
2014-12-31 $0.00 $0.00 x
2015-12-31 $0.00 $0.00 x
2016-12-31 $0.00 $0.00 x
2017-12-31 $0.00 $0.00 x
2019-12-31 $0.00 $0.00 x
2020-12-31 $0.00 $0.00 x
2021-12-31 $0.00 $0.00 x
2022-12-31 $0.00 $0.00 x
2023-12-31 $0.00 $0.00 x
2024-12-31 $0.00 $0.00 x

Capital Efficiency Dashboard

This dashboard shows how efficiently Aerius International Inc utilizes its equity to generate returns, including Return on Equity (ROE) and its components based on the DuPont analysis framework.

Capital Efficiency Insights

  • Current Return on Equity (ROE): 0.00%
  • The company may be facing challenges in efficiently utilizing shareholder equity.
  • DuPont Analysis Breakdown:
  • • Net Profit Margin: 0.00%
  • • Asset Turnover: 0.00x
  • • Equity Multiplier: 0.00x
  • Recent ROE (0.00%) is below the historical average (0.00%), suggesting potential challenges in capital efficiency.

Historical Capital Efficiency Metrics

Year Return on Equity Net Profit Margin Asset Turnover Equity Multiplier Economic Value Added
2008 0.00% 0.00% 0.00x 0.00x $-202.96K
2009 0.00% 0.00% 0.00x 0.00x $-331.56K
2010 0.00% -242518.60% 0.00x 0.00x $-495.93K
2011 0.00% 0.00% 0.00x 0.00x $-80.43K
2012 0.00% -8517.84% 0.00x 0.00x $32.75K
2014 0.00% -27.41% 0.06x 0.00x $33.35K
2015 0.00% 0.00% 0.00x 0.00x $-73.95K
2016 0.00% 0.00% 0.00x 0.00x $27.99K
2017 0.00% 0.00% 0.00x 0.00x $55.66K
2021 0.00% 0.00% 0.00x 0.00x $-6.52K
2022 0.00% 0.00% 0.00x 0.00x $-231.75K
2023 0.00% 0.00% 0.00x 0.00x $-6.65K
2024 0.00% 0.00% 0.00x 0.00x $-17.36K

Industry Comparison

This section compares Aerius International Inc's net assets metrics with peer companies in the Shell Companies industry.

Industry Context

  • Industry: Shell Companies
  • Average net assets among peers: $36,677,338
  • Average return on equity (ROE) among peers: -64.57%

Peer Company Comparison

Company Net Assets Return on Equity Debt-to-Equity Market Cap
Aerius International Inc (AERS) $-66.88K 0.00% N/A $17.79
Artius II Acquisition Inc. Class A Ordinary Shares (AACB) $-60.27K 0.00% 0.00x $198.37 Million
Artius II Acquisition Inc. Units (AACBU) $-60.27K 0.00% 0.00x $205.28 Million
Ares Acquisition Corporation II (AACT-UN) $931.34 Million 0.00% 0.08x $399.77 Million
AA Mission Acquisition Corp. (AAM-UN) $-559.90 Million 0.00% 0.00x $349.76 Million
Global Acquisitions Corporation (AASP) $3.80 Million -5.26% 0.34x $15.42 Million
ABV Consulting Inc (ABVN) $8.75K -623.31% 2.50x $461.96K
Atlantic Coastal Acquisition Corp II (ACAB) $-8.52 Million 0.00% 0.00x $2.44 Million
Annabidiol Corp (ACBD) $-501.57K 0.00% 0.00x $13.62K
ACRO Biomedical Co Ltd (ACBM) $685.87K -17.12% 0.46x $30.04K
Huaizhong Health Group Inc (ADAD) $-19.47K 0.00% 0.00x $3.15K